Literature DB >> 29702325

Amorphous tantalum oxyhydroxide homojunction: In situ construction for enhanced hydrogen production.

Nannan Zhang1, Guangshe Li1, Tengfeng Xie2, Liping Li3.   

Abstract

An amorphous tantalum oxyhydroxide TaOx(OH)y homojunction is constructed by anchoring TaOx(OH)y (2x + y = 5) nanoparticles (NPs, size: 4-10 nm) in situ on the surface of TaOx(OH)y sphere (SP). The formation of amorphous homojunction (TaOx(OH)y NPs/SP) is demonstrated by detailed characterizations of transmission electron microscopy, thermogravimetric analysis/mass spectrometer, Fourier transfer infrared spectra and X-ray photoelectron spectroscopy. In the absence of cocatalyst, the constructed amorphous homojunction exhibits a photocatalytic H2 evolution rate of 311.1 μmol/g/h, about 5, 40 and 1000 times higher than that of 66.8 μmol/g/h for bare TaOx(OH)y SP, 7.6 μmol/g/h for commercial Ta2O5, and 0.3 μmol/g/h for the most widely used photocatalyst P25 (mixed-phase titania). The splendid performance is attributed to the special amorphous homojunction that produces a type-II band alignment and robust separation of photo-excited charge carriers, as uncovered by ultraviolet photoelectron, photoluminescence spectroscopy, and surface/transient photovoltage data. Our findings for amorphous homojunction may provide a new strategy of developing effective noncrystalline photocatalysts.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amorphous homojunction; In situ interface construction; Photocatalytic H(2) production; Stable recycling; TaO(x)(OH)(y); Type-II band alignment

Year:  2018        PMID: 29702325     DOI: 10.1016/j.jcis.2018.04.066

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

1.  Alcohol solvothermal reduction for commercial P25 to harvest weak visible light and fabrication of the resulting floating photocatalytic spheres.

Authors:  Ting Wang; Yao Li; Jia-Hao Pan; Yan-Ling Zhang; Li-Guang Wu; Chun-Ying Dong; Chun-Juan Li
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.